High Response Seen for Chemo in Seniors With High-Risk AML

THURSDAY, June 20, 2019 -- A substantial proportion of older patients with high-risk acute myeloid leukemia (AML) treated with chemotherapy are long-term survivors, according to research published online June 7 in Cancer Medicine. Sarah Bertoli,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news